Emcure Pharmaceuticals Limited (BOM:544210)
India · Delayed Price · Currency is INR 1,592.25
-37.85 (-2.32%)
At close: Apr 21, 2026
Emcure Pharmaceuticals Market Cap
Emcure Pharmaceuticals has a market cap or net worth of 301.96 billion as of April 21, 2026. Its market cap has increased by 51.88% in one year.
Market Cap
301.96B
Enterprise Value
314.85B
Revenue
88.50B
Ranking
n/a
PE Ratio
34.71
Stock Price
1,592.25
Market Cap Chart
Since July 10, 2024, Emcure Pharmaceuticals's market cap has increased from 256.95B to 301.96B, an increase of 17.52%. That is a compound annual growth rate of 9.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 301.96B | 16.73% |
| Dec 31, 2025 | 258.67B | -5.64% |
| Dec 31, 2024 | 274.13B | 6.68% |
| Jul 10, 2024 | 256.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dr. Reddy's Laboratories | 1.02T |
| Abbott India | 539.62B |
| GlaxoSmithKline Pharmaceuticals | 411.14B |
| J. B. Chemicals & Pharmaceuticals | 319.98B |
| AstraZeneca Pharma India | 213.00B |
| Granules India | 165.57B |
| Rubicon Research | 151.79B |
| Jubilant Pharmova | 143.25B |